insulin glargine

Ukraine

Drugs containing this active substance

  • AYLAR

    The drug is used for the treatment of diabetes mellitus in adults, adolescents, and children aged 2 years and older.

    Form: solution for injection

    Active substance Dosage
    insulin glargine 100 units/ml

    ATC: A10AE04

    Manufacturer: Farmak JSC

  • The drug is intended for the treatment of diabetes mellitus in adults, adolescents, and children aged 2 years and older.

    Form: solution for injection

    Active substance Dosage
    insulin glargine 100 IU/ml

    ATC: A10AE04

    Manufacturer: Sanofi-Aventis Deutschland GmbH

  • The drug is used to treat adults with type 2 diabetes to improve blood sugar control as an adjunct to diet, physical exercise, and metformin (or SGLT2 inhibitors).

    Form: solution for injection

    Active substance Dosage
    insulin glargine 100 units/ml
    lixisenatide 33 mcg/ml

    ATC: A10AE54

    Manufacturer: Sanofi-Aventis Deutschland GmbH

  • The drug is used to treat adults with type 2 diabetes to improve blood sugar control as an adjunct to diet, physical exercise, and metformin (or SGLT2 inhibitors).

    Form: solution for injection

    Active substance Dosage
    insulin glargine 100 units/ml
    lixisenatide 50 mcg/ml

    ATC: A10AE54

    Manufacturer: Sanofi-Aventis Deutschland GmbH

  • The drug is intended for the treatment of diabetes mellitus in adults, adolescents, and children aged 6 years and older.

    Form: solution for injection

    Active substance Dosage
    insulin glargine 300 IU/ml

    ATC: A10AE04

    Manufacturer: Sanofi-Aventis Deutschland GmbH